Skip to content
Review Open access

Gut microbiota–innate immune crosstalk in the initiation and progression of CRC: mechanisms and therapeutic potential

Sep 2026 · Frontiers in Immunology · Vol 17 · 0 citations · 172 references
Medicine

TL;DR

This review focuses on the bidirectional interactions between the gut microbiota and innate immunity in CRC, systematically summarizing their molecular mechanisms, associated pathological processes, and advances in microbiota-targeted interventions, with particular emphasis on distinguishing among different types of evidence, experimental contexts, and levels of causal certainty.

Abstract

Colorectal cancer (CRC) is a common malignancy of the digestive system, and its initiation and progression are associated with multiple factors, including genetic alterations, environmental exposures, changes in the gut microbiota, and disruption of immune homeostasis. In recent years, evidence from human observational studies, animal models, and in vitro experiments has shown that the gut microbiota can influence Toll-like receptor and NOD-like receptor signaling, NF-κB activation, the NLRP3 inflammasome, and immunometabolic pathways through multiple mechanisms, including microbial structural components, metabolic signals, virulence factors, and outer membrane vesicles. These effects are associated with functional remodeling of innate immune components such as macrophages, dendritic cells, neutrophils, and natural killer (NK) cells. Conversely, the innate immune system can reshape microbial composition, spatial distribution, and metabolic characteristics through antimicrobial effector molecules, maintenance of the mucosal barrier, release of inflammatory mediators, and phagocytic clearance, indicating a bidirectional regulatory relationship between the gut microbiota and innate immunity. Current evidence suggests that microbiota–innate immune interactions are associated, to varying degrees, with CRC-related pathological processes, including alterations in immune surveillance and the myeloid microenvironment, barrier dysfunction, low-grade inflammation, remodeling of the tumor microenvironment, epithelial–mesenchymal transition-related phenotypes, and immune evasion. Notably, colibactin-associated mutational signatures have been directly demonstrated in the genomes of human CRC tumors, representing one of the relatively rare forms of high-strength mechanistic evidence in microbiota–CRC research. Beyond such a limited number of well-supported mechanisms, however, many specific microbiota–immune interactions and their roles at different pathological stages remain based primarily on animal models, in vitro experiments, or integrative inference, while longitudinal causal evidence in humans remains generally limited. This review focuses on the bidirectional interactions between the gut microbiota and innate immunity in CRC, systematically summarizing their molecular mechanisms, associated pathological processes, and advances in microbiota-targeted interventions, with particular emphasis on distinguishing among different types of evidence, experimental contexts, and levels of causal certainty. In doing so, we aim to provide a more cautious theoretical basis for mechanistic research on the microbiota–immune axis and for the development of precision intervention strategies in CRC.

Read PDF

Similar papers

Review Open access Sep 2026

Gut microbiota–host adaptive immune interactions in type 2 diabetes mellitus: mechanisms, disease progression, and microbiota-based therapeutic strategies

Type 2 diabetes mellitus (T2DM) is a prevalent metabolic disorder whose development and progression are influenced not only by genetic susceptibility, obesity, and lifestyle-related factors but also by gut microbiota dysbiosis, chronic low-grade inflammation, and disruption of immunometabolic homeostasis. The gut micro...

Yi Cheng, Han-Xi Zhao, Li Lin et al. · 0 citations
Review Open access Oct 2026

Microbiological mechanisms of immune response modulation: clinical implications

The human microbiota is a major regulator of immune development, mucosal barrier integrity, and systemic immune tone. Its effects are mediated by microbe-associated molecular patterns, pattern-recognition receptors, microbial metabolites such as short-chain fatty acids, tryptophan-derived indoles, secondary bile acids...

A. Deptuła, Aleksandra Ćwirko-Godycka, A. Majcherczak et al. · 0 citations
Review Open access Aug 2026

Gut-microbiota-mediated host immune modulation: mechanisms, pathological dysbiosis, and therapeutic frontiers

The mammalian immune system has evolved in constant dialogue with its diverse microbiota, forming an ecological and molecular partnership that is fundamental to health. This review examines how microbial communities shape immunity across developmental and functional axes, the immunological consequences of dysbiosis dur...

P. Babu, V. Prakash, Suja Subhash et al. · 0 citations
Review Open access Oct 2026

Crosstalk between gut microbiota-associated metabolites and adaptive immunity in cholecystitis: a conceptual mechanistic framework and potential therapeutic implications

The pathogenesis of cholecystitis involves the complex interplay of bile stasis, microbial dysbiosis, metabolic disturbances, and immune responses. Gut microbiota-associated metabolites can modulate adaptive immune components, including T helper 17 (Th17) cells, regulatory T (Treg) cells, CD8+ T cells, and B cells, thr...

Xin-Qi Wang, Tao Zhang, Zhe-Tan Ren et al. · 0 citations
Review Open access Oct 2026

TLR Signaling Beyond Immunity: Emerging Roles in Cell Migration, Metabolism, Development, and Host–Microbiome Crosstalk

Recent findings support a broader view of TLR signaling as an integrative signaling hub that links immunity with cell migration, metabolism, development, and host–microbiome crosstalk. In cell migration, TLRs exert context-dependent effects through chemokine receptor regulation, adhesion and cytoskeletal modulation, an...

Li Liu, H. Spaink · 0 citations
Review Open access Aug 2026

From gut microbiota-driven mucosal barrier disruption to myeloid-dominant immunosuppressive niches in colorectal cancer

Colorectal cancer (CRC) develops within a mucosal ecosystem in which epithelial barrier function, colonizing microbes, inflammatory signaling, and immune cell composition are closely interdependent. Immune checkpoint inhibitors have significantly altered treatment outcomes in patients with mismatch repair-deficient or...

Na Lu, Lei Zhang, Han-Yu Sun et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.